Search results
Results from the WOW.Com Content Network
The Center for International Blood and Marrow Transplant Research (CIBMTR) is a research collaboration between the National Marrow Donor Program and the Medical College of Wisconsin. [ 1 ] [ 2 ] CIBMTR provides information to the medical and scientific communities .
These survival rates may be improved in patients able to withstand follow-up bone marrow transplantation. Newer drug approaches using Pralatrexate , Romidepsin , Brentuximab vedotin , Belinostat , Bendamustine , lenalidomide , and alisertib have shown activity against CTCL, NOS and are being further studied in randomized trials for use in ...
For those with severe bone marrow failure, the cumulative incidence of resulting stem cell transplantation or death was greater than 70% by individuals 60 years of age. [13] The incidence of bone marrow failure is triphasic: one peak at two to five years during childhood (due to inherited causes), and two peaks in adulthood, between 20 and 25 ...
Human infectious diseases may be characterized by their case fatality rate (CFR), the proportion of people diagnosed with a disease who die from it (cf. mortality rate).It should not be confused with the infection fatality rate (IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease.
H5N1 flu is a concern due to the fact that its global spread may constitute a pandemic threat. The yardstick for human mortality from H5N1 is the case-fatality rate (CFR); the ratio of the number of confirmed human deaths resulting from infection of H5N1 to the number of those confirmed cases of infection with the virus. For example, if there ...
The first physician to perform a successful human bone-marrow transplant on a disease other than cancer was Robert A. Good at the University of Minnesota in 1968. [75] In 1975, John Kersey, also of the University of Minnesota, performed the first successful bone-marrow transplant to cure lymphoma.
In addition, as bone marrow transplantation is frequently used to treat cancer, mainly leukemias, donor T-cells have proven to have a valuable graft-versus-tumor effect. [24] A great deal of current research on allogeneic bone marrow transplantation involves attempts to separate the undesirable graft-vs-host disease aspects of T-cell physiology ...
Date of transplant Survival Reference Sandro (1945–2010) Argentine singer and actor. He died after complications of a heart–lung transplant. November 20, 2009 45 days [31] Ann Harrison (1944–2001) Recipient and long term survivor of the world's first human double-lung transplant November 26, 1986 15 years [90] Charity Sunshine Tillemann-Dick